Cingulate Inc.(CING)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
CING Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Cingulate Inc. (CING), a Healthcare sector company. CING is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), Cingulate Inc. reports net income of $-9.3M, free cash flow of $-7.0M. Top institutional holders of CING by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, Kestra Advisory Services,, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. CING trades on the Nasdaq exchange and files with the SEC under CIK 1862150. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CING daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cingulate Inc. directly from SEC EDGAR.
Net Income
Q1 2026
$-9.3M
Free Cash Flow
Q1 2026
$-7.0M
Get alerted when CING's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Cingulate Inc. including:
Top Institutional Holders of CING
VANGUARD CAPITAL MANAGEMENT LLC
$1.9M308,967 shKestra Advisory Services, LLC
$869.4K140,000 shGEODE CAPITAL MANAGEMENT, LLC
$629.8K101,373 shMARSHALL WACE, LLP
$577.1K92,934 shJANE STREET GROUP, LLC
$564.3K90,867 shXTX Topco Ltd
$332.3K53,503 shBCV Asset Management Inc.
$317.9K51,200 shVANGUARD FIDUCIARY TRUST CO
$311.0K50,074 shQuadrature Capital Ltd
$216.3K34,839 shRENAISSANCE TECHNOLOGIES LLC
$198.0K31,888 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.9M | 308,967 |
| Kestra Advisory Services, LLC | $869.4K | 140,000 |
| GEODE CAPITAL MANAGEMENT, LLC | $629.8K | 101,373 |
| MARSHALL WACE, LLP | $577.1K | 92,934 |
| JANE STREET GROUP, LLC | $564.3K | 90,867 |
| XTX Topco Ltd | $332.3K | 53,503 |
| BCV Asset Management Inc. | $317.9K | 51,200 |
| VANGUARD FIDUCIARY TRUST CO | $311.0K | 50,074 |
| Quadrature Capital Ltd | $216.3K | 34,839 |
| RENAISSANCE TECHNOLOGIES LLC | $198.0K | 31,888 |
More Healthcare Companies
View all Healthcare →Put CING on your watchlist
Track score changes the day Cingulate Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CING a good stock to buy?
13F Pro's AI-powered analysis of Cingulate Inc. (CING) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CING are available on the CING stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own CING?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CING. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Cingulate Inc.'s investment landscape.